{"transactions":[{"id":4638069,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-10-08T21:24:27.000Z","date":"2026-10-08","kind":"exercise","planned":true,"acquired":false,"shares":619,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3095,"derivative":{"exercise_price":72.68,"exercise_date":"2021-05-07","expiration_date":"2027-05-06","underlying":"Common Stock","underlying_shares":619},"source":{"system":"sec-edgar","filing":"0001225208-26-008338","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2004380/000122520826008338/doc4.xml","form_type":"4"}},{"id":4638068,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-10-08T21:24:27.000Z","date":"2026-10-08","kind":"sale","planned":true,"acquired":false,"shares":619,"price":85.65,"value":53017.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."}],"balance_after":40033.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-008338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2004380/000122520826008338/doc4.xml","form_type":"4"}},{"id":4638067,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-10-08T21:24:27.000Z","date":"2026-10-08","kind":"exercise","planned":true,"acquired":true,"shares":619,"price":72.68,"value":44988.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."}],"balance_after":40652.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-008338","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2004380/000122520826008338/doc4.xml","form_type":"4"}},{"id":4617418,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2026-09-14T22:04:02.000Z","date":"2026-09-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":568,"price":84.37,"value":47922.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e)."}],"balance_after":19370.5581,"source":{"system":"sec-edgar","filing":"0001225208-26-007812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1991414/000122520826007812/doc4.xml","form_type":"4"}},{"id":4617417,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2026-09-14T22:04:02.000Z","date":"2026-09-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":355,"price":86.77,"value":30803.35,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e)."}],"balance_after":19938.5581,"source":{"system":"sec-edgar","filing":"0001225208-26-007812","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1991414/000122520826007812/doc4.xml","form_type":"4"}},{"id":4617419,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":18485,"kind":"person","name":"Dahl Andrew M.","position":1,"cik":"0002022347","reported_name":"Dahl Andrew M.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2026-09-14T22:04:01.000Z","date":"2026-09-13","kind":"tax_withholding","planned":false,"acquired":false,"shares":253,"price":84.37,"value":21345.61,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e)."}],"balance_after":14615.41,"source":{"system":"sec-edgar","filing":"0001225208-26-007811","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2022347/000122520826007811/doc4.xml","form_type":"4"}},{"id":4616474,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT, Surgical & IHFM"}}],"security":"Common Stock","published_at":"2026-09-11T23:15:12.000Z","date":"2026-09-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":398,"price":86.77,"value":34534.46,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e)."}],"balance_after":43926,"source":{"system":"sec-edgar","filing":"0001225208-26-007775","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1740963/000122520826007775/doc4.xml","form_type":"4"}},{"id":4616477,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-09-11T23:15:10.000Z","date":"2026-09-11","kind":"exercise","planned":true,"acquired":false,"shares":619,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":3714,"derivative":{"exercise_price":72.68,"exercise_date":"2021-05-07","expiration_date":"2027-05-06","underlying":"Common Stock","underlying_shares":619},"source":{"system":"sec-edgar","filing":"0001225208-26-007774","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2004380/000122520826007774/doc4.xml","form_type":"4"}},{"id":4616476,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-09-11T23:15:10.000Z","date":"2026-09-11","kind":"sale","planned":true,"acquired":false,"shares":619,"price":87.51,"value":54168.69,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."}],"balance_after":40033.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-007774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2004380/000122520826007774/doc4.xml","form_type":"4"}},{"id":4616475,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-09-11T23:15:10.000Z","date":"2026-09-11","kind":"exercise","planned":true,"acquired":true,"shares":619,"price":72.68,"value":44988.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."}],"balance_after":40652.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-007774","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2004380/000122520826007774/doc4.xml","form_type":"4"}},{"id":672276,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":18485,"kind":"person","name":"Dahl Andrew M.","position":1,"cik":"0002022347","reported_name":"Dahl Andrew M.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2026-08-31T21:47:55.000Z","date":"2026-08-31","kind":"sale","planned":false,"acquired":false,"shares":544,"price":91.055,"value":49533.92,"ownership":{"direct":true},"balance_after":14868.41,"source":{"system":"sec-edgar","filing":"0001225208-26-007408","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826007408/doc4.xml","form_type":"4"}},{"id":673287,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":18846,"kind":"person","name":"Bruls Annette","position":1,"cik":"0002032351","reported_name":"Bruls Annette","relationship":{"officer":true,"officer_title":"CVP, EMEACLA"}}],"security":"Common Stock","published_at":"2026-08-28T20:32:52.000Z","date":"2026-08-28","kind":"sale","planned":false,"acquired":false,"shares":2644,"price":89.98,"value":237907.12,"ownership":{"direct":true},"balance_after":17984,"source":{"system":"sec-edgar","filing":"0001225208-26-007377","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826007377/doc4.xml","form_type":"4"}},{"id":675434,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT, Surgical & IHFM"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-08-26T22:36:41.000Z","date":"2026-08-26","kind":"exercise","planned":false,"acquired":false,"shares":31800,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":0,"derivative":{"exercise_price":72.68,"exercise_date":"2021-05-07","expiration_date":"2027-05-06","underlying":"Common Stock","underlying_shares":31800},"source":{"system":"sec-edgar","filing":"0001225208-26-007335","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826007335/doc4.xml","form_type":"4"}},{"id":675433,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT, Surgical & IHFM"}}],"security":"Common Stock","published_at":"2026-08-26T22:36:41.000Z","date":"2026-08-26","kind":"sale","planned":false,"acquired":false,"shares":30646,"price":90.9922,"value":2788546.9612,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $90.645 to $91.640. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":44324,"source":{"system":"sec-edgar","filing":"0001225208-26-007335","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826007335/doc4.xml","form_type":"4"}},{"id":675432,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT, Surgical & IHFM"}}],"security":"Common Stock","published_at":"2026-08-26T22:36:41.000Z","date":"2026-08-26","kind":"sale","planned":false,"acquired":false,"shares":1154,"price":91.7614,"value":105892.6556,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $91.660 to $91.975. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":74970,"source":{"system":"sec-edgar","filing":"0001225208-26-007335","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826007335/doc4.xml","form_type":"4"}},{"id":675431,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT, Surgical & IHFM"}}],"security":"Common Stock","published_at":"2026-08-26T22:36:41.000Z","date":"2026-08-26","kind":"exercise","planned":false,"acquired":true,"shares":31800,"price":72.68,"value":2311224.0,"ownership":{"direct":true},"balance_after":76124,"source":{"system":"sec-edgar","filing":"0001225208-26-007335","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826007335/doc4.xml","form_type":"4"}},{"id":675430,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2026-08-26T22:00:29.000Z","date":"2026-08-26","kind":"sale","planned":false,"acquired":false,"shares":1240,"price":91.465,"value":113416.6,"ownership":{"direct":true},"balance_after":20293.5581,"source":{"system":"sec-edgar","filing":"0001225208-26-007332","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826007332/doc4.xml","form_type":"4"}},{"id":691287,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-08-11T21:07:58.000Z","date":"2026-08-11","kind":"exercise","planned":true,"acquired":false,"shares":619,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4333,"derivative":{"exercise_price":72.68,"exercise_date":"2021-05-07","expiration_date":"2027-05-06","underlying":"Common Stock","underlying_shares":619},"source":{"system":"sec-edgar","filing":"0001225208-26-007065","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826007065/doc4.xml","form_type":"4"}},{"id":691286,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-08-11T21:07:58.000Z","date":"2026-08-11","kind":"sale","planned":true,"acquired":false,"shares":619,"price":92.03,"value":56966.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."}],"balance_after":40033.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-007065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826007065/doc4.xml","form_type":"4"}},{"id":691285,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-08-11T21:07:58.000Z","date":"2026-08-11","kind":"exercise","planned":true,"acquired":true,"shares":619,"price":72.68,"value":44988.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."}],"balance_after":40652.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-007065","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826007065/doc4.xml","form_type":"4"}},{"id":700925,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2026-07-30T21:30:50.000Z","date":"2026-07-30","kind":"sale","planned":false,"acquired":false,"shares":146.3127,"price":86.0338,"value":12587.83756926,"ownership":{"direct":true},"balance_after":21533.5581,"source":{"system":"sec-edgar","filing":"0001225208-26-006853","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006853/doc4.xml","form_type":"4"}},{"id":702517,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-07-28T23:40:47.000Z","date":"2026-07-28","kind":"exercise","planned":false,"acquired":false,"shares":9628,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":9628,"derivative":{"exercise_price":74.02,"exercise_date":"2024-09-14","expiration_date":"2030-09-13","underlying":"Common Stock","underlying_shares":9628},"source":{"system":"sec-edgar","filing":"0001225208-26-006777","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006777/doc4.xml","form_type":"4"}},{"id":702516,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2026-07-28T23:40:47.000Z","date":"2026-07-28","kind":"sale","planned":false,"acquired":false,"shares":9628,"price":85.06,"value":818957.68,"ownership":{"direct":true},"balance_after":21679.8708,"source":{"system":"sec-edgar","filing":"0001225208-26-006777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006777/doc4.xml","form_type":"4"}},{"id":702515,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2026-07-28T23:40:47.000Z","date":"2026-07-28","kind":"exercise","planned":false,"acquired":true,"shares":9628,"price":74.02,"value":712664.56,"ownership":{"direct":true},"balance_after":31307.8708,"source":{"system":"sec-edgar","filing":"0001225208-26-006777","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006777/doc4.xml","form_type":"4"}},{"id":703154,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-07-27T22:59:21.000Z","date":"2026-07-27","kind":"sale","planned":false,"acquired":false,"shares":2920.5511,"price":83.9342,"value":245134.12013762,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":8915.6499,"source":{"system":"sec-edgar","filing":"0001225208-26-006743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006743/doc4.xml","form_type":"4"}},{"id":703153,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-07-27T22:59:21.000Z","date":"2026-07-27","kind":"gift","planned":false,"acquired":true,"shares":319.6499,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":11836.201,"source":{"system":"sec-edgar","filing":"0001225208-26-006743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006743/doc4.xml","form_type":"4"}},{"id":703152,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-07-27T22:59:21.000Z","date":"2026-07-27","kind":"gift","planned":false,"acquired":false,"shares":319.6499,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":98845,"source":{"system":"sec-edgar","filing":"0001225208-26-006743","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006743/doc4.xml","form_type":"4"}},{"id":710829,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":18846,"kind":"person","name":"Bruls Annette","position":1,"cik":"0002032351","reported_name":"Bruls Annette","relationship":{"officer":true,"officer_title":"CVP, EMEACLA"}}],"security":"Common Stock","published_at":"2026-07-13T20:09:27.000Z","date":"2026-07-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":109,"price":92.21,"value":10050.89,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e)."}],"balance_after":20628,"source":{"system":"sec-edgar","filing":"0001225208-26-006591","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006591/doc4.xml","form_type":"4"}},{"id":711475,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":31091,"kind":"person","name":"Mistras Theodora","position":1,"cik":"0002013495","reported_name":"Mistras Theodora","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Performance Rights","published_at":"2026-07-10T21:11:14.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":12325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on July 9, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on July 9, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards."}],"balance_after":12325,"derivative":{"exercise_date":"2029-07-09","underlying":"Common Stock","underlying_shares":12325},"source":{"system":"sec-edgar","filing":"0001225208-26-006578","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006578/doc4.xml","form_type":"4"}},{"id":711474,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":31091,"kind":"person","name":"Mistras Theodora","position":1,"cik":"0002013495","reported_name":"Mistras Theodora","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-07-10T21:11:14.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":61800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options were granted on July 9, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":61800,"derivative":{"exercise_price":91.33,"exercise_date":"2027-07-09","expiration_date":"2033-07-08","underlying":"Common Stock","underlying_shares":61800},"source":{"system":"sec-edgar","filing":"0001225208-26-006578","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006578/doc4.xml","form_type":"4"}},{"id":711473,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":31091,"kind":"person","name":"Mistras Theodora","position":1,"cik":"0002013495","reported_name":"Mistras Theodora","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-10T21:11:14.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":12325,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units were granted on July 9, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":99920,"source":{"system":"sec-edgar","filing":"0001225208-26-006578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006578/doc4.xml","form_type":"4"}},{"id":711472,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":31091,"kind":"person","name":"Mistras Theodora","position":1,"cik":"0002013495","reported_name":"Mistras Theodora","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-07-10T21:11:14.000Z","date":"2026-07-09","kind":"grant","planned":false,"acquired":true,"shares":87595,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on July 9, 2026, under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest as follows: 43.75% on the first anniversary of May 29, 2026 (the \"Start Date\"), 50% on the second anniversary of the Start Date, and the remaining 6.25% on the third anniversary of the Start Date."}],"balance_after":87595,"source":{"system":"sec-edgar","filing":"0001225208-26-006578","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006578/doc4.xml","form_type":"4"}},{"id":711471,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-07-10T21:04:11.000Z","date":"2026-07-10","kind":"exercise","planned":true,"acquired":false,"shares":619,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4952,"derivative":{"exercise_price":72.68,"exercise_date":"2021-05-07","expiration_date":"2027-05-06","underlying":"Common Stock","underlying_shares":619},"source":{"system":"sec-edgar","filing":"0001225208-26-006576","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006576/doc4.xml","form_type":"4"}},{"id":711470,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-07-10T21:04:11.000Z","date":"2026-07-10","kind":"sale","planned":true,"acquired":false,"shares":619,"price":91.7,"value":56762.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."}],"balance_after":40033.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-006576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006576/doc4.xml","form_type":"4"}},{"id":711469,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-07-10T21:04:11.000Z","date":"2026-07-10","kind":"exercise","planned":true,"acquired":true,"shares":619,"price":72.68,"value":44988.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."}],"balance_after":40652.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-006576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006576/doc4.xml","form_type":"4"}},{"id":713947,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-07-07T22:56:18.000Z","date":"2026-07-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":377,"price":95.18,"value":35882.86,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e)."}],"balance_after":40033.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-006535","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006535/doc4.xml","form_type":"4"}},{"id":723189,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-07-01T00:01:07.000Z","date":"2026-06-30","kind":"exercise","planned":true,"acquired":false,"shares":619,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5571,"derivative":{"exercise_price":72.68,"exercise_date":"2021-05-07","expiration_date":"2027-05-06","underlying":"Common Stock","underlying_shares":619},"source":{"system":"sec-edgar","filing":"0001225208-26-006263","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006263/doc4.xml","form_type":"4"}},{"id":723188,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-07-01T00:01:07.000Z","date":"2026-06-30","kind":"sale","planned":true,"acquired":false,"shares":619,"price":91.4002,"value":56576.7238,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $91.185 to $91.650. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":40410.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-006263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006263/doc4.xml","form_type":"4"}},{"id":723187,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-07-01T00:01:07.000Z","date":"2026-06-30","kind":"exercise","planned":true,"acquired":true,"shares":619,"price":72.68,"value":44988.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."}],"balance_after":41029.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-006263","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006263/doc4.xml","form_type":"4"}},{"id":735009,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-06-18T00:19:12.000Z","date":"2026-06-17","kind":"sale","planned":true,"acquired":false,"shares":523,"price":87.92,"value":45982.16,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025."}],"balance_after":11516.5511,"source":{"system":"sec-edgar","filing":"0001225208-26-006103","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826006103/doc4.xml","form_type":"4"}},{"id":759256,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":18485,"kind":"person","name":"Dahl Andrew M.","position":1,"cik":"0002022347","reported_name":"Dahl Andrew M.","relationship":{"officer":true,"officer_title":"SVP, Corporate Controller"}}],"security":"Common Stock","published_at":"2026-05-29T20:44:17.000Z","date":"2026-05-29","kind":"sale","planned":false,"acquired":false,"shares":567.5266,"price":86.08,"value":48852.689728,"ownership":{"direct":true},"balance_after":15334.0948,"source":{"system":"sec-edgar","filing":"0001225208-26-005647","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005647/doc4.xml","form_type":"4"}},{"id":762613,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-05-27T23:28:36.000Z","date":"2026-05-27","kind":"sale","planned":false,"acquired":false,"shares":23145,"price":86.4201,"value":2000193.2145,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $86.27 to $86.57. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":98611,"source":{"system":"sec-edgar","filing":"0001225208-26-005610","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005610/doc4.xml","form_type":"4"}},{"id":766707,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT & Surgical"}}],"security":"Common Stock","published_at":"2026-05-22T20:35:58.000Z","date":"2026-05-22","kind":"sale","planned":false,"acquired":false,"shares":1500,"price":84.6035,"value":126905.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $84.6002 to $84.6050. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":44324,"source":{"system":"sec-edgar","filing":"0001225208-26-005576","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005576/doc4.xml","form_type":"4"}},{"id":775719,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-05-18T21:29:30.000Z","date":"2026-05-18","kind":"exercise","planned":true,"acquired":false,"shares":620,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":6190,"derivative":{"exercise_price":72.68,"exercise_date":"2021-05-07","expiration_date":"2027-05-06","underlying":"Common Stock","underlying_shares":620},"source":{"system":"sec-edgar","filing":"0001225208-26-005464","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005464/doc4.xml","form_type":"4"}},{"id":775718,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-05-18T21:29:30.000Z","date":"2026-05-18","kind":"sale","planned":true,"acquired":false,"shares":620,"price":81.14,"value":50306.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."}],"balance_after":40410.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-005464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005464/doc4.xml","form_type":"4"}},{"id":775717,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-05-18T21:29:30.000Z","date":"2026-05-18","kind":"exercise","planned":true,"acquired":true,"shares":620,"price":72.68,"value":45061.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on February 13, 2026."}],"balance_after":41030.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-005464","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005464/doc4.xml","form_type":"4"}},{"id":775716,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-05-18T21:28:28.000Z","date":"2026-05-15","kind":"sale","planned":false,"acquired":false,"shares":8000,"price":81.8216,"value":654572.8,"ownership":{"direct":false,"nature":"401(k)"},"balance_after":30969.5756,"source":{"system":"sec-edgar","filing":"0001225208-26-005463","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005463/doc4.xml","form_type":"4"}},{"id":775715,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-05-18T21:28:28.000Z","date":"2026-05-15","kind":"sale","planned":false,"acquired":false,"shares":9968,"price":82.0732,"value":818105.6576,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This transaction was executed in multiple trades at prices ranging from $81.975 to $82.260. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":22798.2532,"source":{"system":"sec-edgar","filing":"0001225208-26-005463","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005463/doc4.xml","form_type":"4"}},{"id":783159,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Performance Rights","published_at":"2026-05-12T20:55:45.000Z","date":"2026-05-11","kind":"exercise","planned":true,"acquired":false,"shares":47207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"These Performance Rights expire on May 10, 2030."}],"balance_after":0,"derivative":{"exercise_date":"2026-05-11","underlying":"Common Stock","underlying_shares":47207},"source":{"system":"sec-edgar","filing":"0001225208-26-005172","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005172/doc4.xml","form_type":"4"}},{"id":783158,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T20:55:45.000Z","date":"2026-05-12","kind":"sale","planned":true,"acquired":false,"shares":35506,"price":77.9238,"value":2766762.4428,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $77.375 to $78.360. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":12039.5511,"source":{"system":"sec-edgar","filing":"0001225208-26-005172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005172/doc4.xml","form_type":"4"}},{"id":783157,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T20:55:45.000Z","date":"2026-05-12","kind":"sale","planned":true,"acquired":false,"shares":845,"price":78.4027,"value":66250.2815,"ownership":{"direct":false,"nature":"By Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $78.390 to $78.430. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":47545.5511,"source":{"system":"sec-edgar","filing":"0001225208-26-005172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005172/doc4.xml","form_type":"4"}},{"id":783156,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T20:55:45.000Z","date":"2026-05-12","kind":"gift","planned":true,"acquired":true,"shares":26640,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":48390.5511,"source":{"system":"sec-edgar","filing":"0001225208-26-005172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005172/doc4.xml","form_type":"4"}},{"id":783155,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T20:55:45.000Z","date":"2026-05-12","kind":"gift","planned":true,"acquired":false,"shares":26640,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":99164.6499,"source":{"system":"sec-edgar","filing":"0001225208-26-005172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005172/doc4.xml","form_type":"4"}},{"id":783154,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T20:55:45.000Z","date":"2026-05-11","kind":"tax_withholding","planned":true,"acquired":false,"shares":26198,"price":79.96,"value":2094792.08,"ownership":{"direct":true},"balance_after":125804.6499,"source":{"system":"sec-edgar","filing":"0001225208-26-005172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005172/doc4.xml","form_type":"4"}},{"id":783153,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T20:55:45.000Z","date":"2026-05-11","kind":"exercise","planned":true,"acquired":true,"shares":47207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":157491.6499,"source":{"system":"sec-edgar","filing":"0001225208-26-005172","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005172/doc4.xml","form_type":"4"}},{"id":783152,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Performance Rights","published_at":"2026-05-12T20:52:39.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":13457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These Performance Rights expire on May 10, 2030."}],"balance_after":0,"derivative":{"exercise_date":"2026-05-11","underlying":"Common Stock","underlying_shares":13457},"source":{"system":"sec-edgar","filing":"0001225208-26-005171","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005171/doc4.xml","form_type":"4"}},{"id":783151,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-05-12T20:52:39.000Z","date":"2026-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":7469,"price":79.96,"value":597221.24,"ownership":{"direct":true},"balance_after":32766.2532,"source":{"system":"sec-edgar","filing":"0001225208-26-005171","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005171/doc4.xml","form_type":"4"}},{"id":783150,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-05-12T20:52:39.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":13457,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":40235.2532,"source":{"system":"sec-edgar","filing":"0001225208-26-005171","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005171/doc4.xml","form_type":"4"}},{"id":783148,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT & Surgical"}}],"security":"Performance Rights","published_at":"2026-05-12T20:50:35.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":13583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These Performance Rights expire on May 10, 2030."}],"balance_after":0,"derivative":{"exercise_date":"2026-05-11","underlying":"Common Stock","underlying_shares":13583},"source":{"system":"sec-edgar","filing":"0001225208-26-005170","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005170/doc4.xml","form_type":"4"}},{"id":783147,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT & Surgical"}}],"security":"Common Stock","published_at":"2026-05-12T20:50:35.000Z","date":"2026-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":7538,"price":79.96,"value":602738.48,"ownership":{"direct":true},"balance_after":45824,"source":{"system":"sec-edgar","filing":"0001225208-26-005170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005170/doc4.xml","form_type":"4"}},{"id":783146,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19646,"kind":"person","name":"Chopra Daveen","position":1,"cik":"0001740963","reported_name":"Chopra Daveen","relationship":{"officer":true,"officer_title":"CVP, TMTT & Surgical"}}],"security":"Common Stock","published_at":"2026-05-12T20:50:35.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":13583,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":53362,"source":{"system":"sec-edgar","filing":"0001225208-26-005170","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005170/doc4.xml","form_type":"4"}},{"id":785477,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Performance Rights","published_at":"2026-05-12T01:59:57.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":19830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"These Performance Rights expire on May 10, 2030."}],"balance_after":0,"derivative":{"exercise_date":"2026-05-11","underlying":"Common Stock","underlying_shares":19830},"source":{"system":"sec-edgar","filing":"0001225208-26-005133","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005133/doc4.xml","form_type":"4"}},{"id":785476,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-12T01:59:57.000Z","date":"2026-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":11004,"price":79.96,"value":879879.84,"ownership":{"direct":true},"balance_after":46740,"source":{"system":"sec-edgar","filing":"0001225208-26-005133","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005133/doc4.xml","form_type":"4"}},{"id":785475,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-12T01:59:57.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":19830,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On May 11, 2023, the Reporting Person was granted a target number of shares covered by restricted stock units with performance-based vesting requirements over a three-year performance period. On May 6, 2026, the Compensation and Governance Committee of the Board of Directors determined that 167.70% of the target number of shares would vest as of May 11, 2026, and the actual number of shares vested are reflected on this Form 4."}],"balance_after":57744,"source":{"system":"sec-edgar","filing":"0001225208-26-005133","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005133/doc4.xml","form_type":"4"}},{"id":785474,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Performance Rights","published_at":"2026-05-12T01:33:41.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards."}],"balance_after":5200,"derivative":{"exercise_date":"2029-05-07","underlying":"Common Stock","underlying_shares":5200},"source":{"system":"sec-edgar","filing":"0001225208-26-005132","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005132/doc4.xml","form_type":"4"}},{"id":785473,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-05-12T01:33:41.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":26400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":26400,"derivative":{"exercise_price":82.76,"exercise_date":"2027-05-07","expiration_date":"2033-05-06","underlying":"Common Stock","underlying_shares":26400},"source":{"system":"sec-edgar","filing":"0001225208-26-005132","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005132/doc4.xml","form_type":"4"}},{"id":785472,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2026-05-12T01:33:41.000Z","date":"2026-05-11","kind":"sale","planned":false,"acquired":false,"shares":593,"price":79.73,"value":47279.89,"ownership":{"direct":true},"balance_after":21679.8708,"source":{"system":"sec-edgar","filing":"0001225208-26-005132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005132/doc4.xml","form_type":"4"}},{"id":785471,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2026-05-12T01:33:41.000Z","date":"2026-05-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":226,"price":82.76,"value":18703.76,"ownership":{"direct":true},"balance_after":22272.8708,"source":{"system":"sec-edgar","filing":"0001225208-26-005132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005132/doc4.xml","form_type":"4"}},{"id":785470,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2026-05-12T01:33:41.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":264,"price":83.2,"value":21964.8,"ownership":{"direct":true},"balance_after":22498.8708,"source":{"system":"sec-edgar","filing":"0001225208-26-005132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005132/doc4.xml","form_type":"4"}},{"id":785469,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":19645,"kind":"person","name":"Markowitz Wayne","position":1,"cik":"0001991414","reported_name":"Markowitz Wayne","relationship":{"officer":true,"officer_title":"CVP, JAPAC"}}],"security":"Common Stock","published_at":"2026-05-12T01:33:41.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":5200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":22762.8708,"source":{"system":"sec-edgar","filing":"0001225208-26-005132","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005132/doc4.xml","form_type":"4"}},{"id":785468,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Performance Rights","published_at":"2026-05-12T01:32:42.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":43800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards."}],"balance_after":43800,"derivative":{"exercise_date":"2029-05-07","underlying":"Common Stock","underlying_shares":43800},"source":{"system":"sec-edgar","filing":"0001225208-26-005131","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005131/doc4.xml","form_type":"4"}},{"id":785467,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-05-12T01:32:42.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":245300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments."}],"balance_after":245300,"derivative":{"exercise_price":82.76,"exercise_date":"2027-05-07","expiration_date":"2033-05-06","underlying":"Common Stock","underlying_shares":245300},"source":{"system":"sec-edgar","filing":"0001225208-26-005131","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005131/doc4.xml","form_type":"4"}},{"id":785466,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T01:32:42.000Z","date":"2026-05-11","kind":"gift","planned":false,"acquired":true,"shares":5489,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":21750.5511,"source":{"system":"sec-edgar","filing":"0001225208-26-005131","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005131/doc4.xml","form_type":"4"}},{"id":785465,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T01:32:42.000Z","date":"2026-05-08","kind":"gift","planned":false,"acquired":true,"shares":4222,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Trust"},"balance_after":16261.5511,"source":{"system":"sec-edgar","filing":"0001225208-26-005131","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005131/doc4.xml","form_type":"4"}},{"id":785464,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T01:32:42.000Z","date":"2026-05-11","kind":"gift","planned":false,"acquired":false,"shares":5489,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":104795.6499,"source":{"system":"sec-edgar","filing":"0001225208-26-005131","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005131/doc4.xml","form_type":"4"}},{"id":785463,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T01:32:42.000Z","date":"2026-05-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":5398,"price":82.76,"value":446738.48,"ownership":{"direct":true},"balance_after":110284.6499,"source":{"system":"sec-edgar","filing":"0001225208-26-005131","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005131/doc4.xml","form_type":"4"}},{"id":785462,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T01:32:42.000Z","date":"2026-05-08","kind":"gift","planned":false,"acquired":false,"shares":4222,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":115682.6499,"source":{"system":"sec-edgar","filing":"0001225208-26-005131","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005131/doc4.xml","form_type":"4"}},{"id":785461,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T01:32:42.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":4153,"price":83.2,"value":345529.6,"ownership":{"direct":true},"balance_after":119904.6499,"source":{"system":"sec-edgar","filing":"0001225208-26-005131","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005131/doc4.xml","form_type":"4"}},{"id":785460,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":28621,"kind":"person","name":"Zovighian Bernard J","position":1,"cik":"0001665141","reported_name":"Zovighian Bernard J","relationship":{"director":true,"officer":true,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-05-12T01:32:42.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":43800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":124057.6499,"source":{"system":"sec-edgar","filing":"0001225208-26-005131","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005131/doc4.xml","form_type":"4"}},{"id":785457,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-05-12T01:32:41.000Z","date":"2026-05-11","kind":"tax_withholding","planned":false,"acquired":false,"shares":362,"price":79.96,"value":28945.52,"ownership":{"direct":true},"balance_after":40410.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-005130","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005130/doc4.xml","form_type":"4"}},{"id":787495,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":13260,"kind":"person","name":"VALERIANI NICHOLAS J","position":1,"cik":"0001263149","reported_name":"VALERIANI NICHOLAS J","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-09T01:18:39.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":5127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders."}],"balance_after":84423,"source":{"system":"sec-edgar","filing":"0001225208-26-005055","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005055/doc4.xml","form_type":"4"}},{"id":787494,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":38195,"kind":"person","name":"Sequeira Ramona","position":1,"cik":"0001811081","reported_name":"Sequeira Ramona","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-09T01:18:38.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":3251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders."}],"balance_after":6779,"source":{"system":"sec-edgar","filing":"0001225208-26-005054","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005054/doc4.xml","form_type":"4"}},{"id":787493,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-09T01:18:37.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":1064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This restricted stock award was granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and is scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders."}],"balance_after":8997,"source":{"system":"sec-edgar","filing":"0001225208-26-005053","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005053/doc4.xml","form_type":"4"}},{"id":787492,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48863,"kind":"person","name":"LORANGER STEVEN R","position":1,"cik":"0001226924","reported_name":"LORANGER STEVEN R","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-09T01:18:37.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":3251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders."}],"balance_after":7933,"source":{"system":"sec-edgar","filing":"0001225208-26-005053","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005053/doc4.xml","form_type":"4"}},{"id":787491,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48303,"kind":"person","name":"LAVIOLETTE PAUL A","position":1,"cik":"0001191249","reported_name":"LAVIOLETTE PAUL A","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-09T01:17:37.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":3251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders."}],"balance_after":17552,"source":{"system":"sec-edgar","filing":"0001225208-26-005052","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005052/doc4.xml","form_type":"4"}},{"id":787490,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":47379,"kind":"person","name":"STONE HEISZ LESLIE","position":1,"cik":"0001235408","reported_name":"STONE HEISZ LESLIE","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-09T01:17:36.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":3251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders."}],"balance_after":34199,"source":{"system":"sec-edgar","filing":"0001225208-26-005051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005051/doc4.xml","form_type":"4"}},{"id":787489,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":45155,"kind":"person","name":"GALLAHUE KIERAN","position":1,"cik":"0001308428","reported_name":"GALLAHUE KIERAN","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-09T01:17:34.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":1064,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This restricted stock award was granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program and is scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders."}],"balance_after":4315,"source":{"system":"sec-edgar","filing":"0001225208-26-005050","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005050/doc4.xml","form_type":"4"}},{"id":787488,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":45155,"kind":"person","name":"GALLAHUE KIERAN","position":1,"cik":"0001308428","reported_name":"GALLAHUE KIERAN","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-09T01:17:34.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":3251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders."}],"balance_after":3251,"source":{"system":"sec-edgar","filing":"0001225208-26-005050","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005050/doc4.xml","form_type":"4"}},{"id":787487,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48862,"kind":"person","name":"Feinberg David T","position":1,"cik":"0001486426","reported_name":"Feinberg David T","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-09T01:17:33.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":3251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders."}],"balance_after":9087,"source":{"system":"sec-edgar","filing":"0001225208-26-005049","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005049/doc4.xml","form_type":"4"}},{"id":787486,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Performance Rights","published_at":"2026-05-09T01:17:31.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":7850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards."}],"balance_after":7850,"derivative":{"exercise_date":"2029-05-07","underlying":"Common Stock","underlying_shares":7850},"source":{"system":"sec-edgar","filing":"0001225208-26-005048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005048/doc4.xml","form_type":"4"}},{"id":787485,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-05-09T01:17:31.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":44000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one month after the grant date in 36 approximately equal monthly installments."}],"balance_after":44000,"derivative":{"exercise_price":82.76,"exercise_date":"2027-05-07","expiration_date":"2033-05-06","underlying":"Common Stock","underlying_shares":44000},"source":{"system":"sec-edgar","filing":"0001225208-26-005048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005048/doc4.xml","form_type":"4"}},{"id":787484,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-05-09T01:17:31.000Z","date":"2026-05-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1038,"price":82.76,"value":85904.88,"ownership":{"direct":true},"balance_after":26778.2532,"source":{"system":"sec-edgar","filing":"0001225208-26-005048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005048/doc4.xml","form_type":"4"}},{"id":787483,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-05-09T01:17:31.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":831,"price":83.2,"value":69139.2,"ownership":{"direct":true},"balance_after":27816.2532,"source":{"system":"sec-edgar","filing":"0001225208-26-005048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005048/doc4.xml","form_type":"4"}},{"id":787482,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":43942,"kind":"person","name":"BOBO DONALD E JR","position":1,"cik":"0001196661","reported_name":"BOBO DONALD E JR","relationship":{"officer":true,"officer_title":"CVP,Strategy/Corp Development"}}],"security":"Common Stock","published_at":"2026-05-09T01:17:31.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":7850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":28647.2532,"source":{"system":"sec-edgar","filing":"0001225208-26-005048","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005048/doc4.xml","form_type":"4"}},{"id":787481,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-09T01:16:34.000Z","date":"2026-05-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":1661,"price":82.76,"value":137464.36,"ownership":{"direct":true},"balance_after":37914,"source":{"system":"sec-edgar","filing":"0001225208-26-005047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005047/doc4.xml","form_type":"4"}},{"id":787480,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":33138,"kind":"person","name":"Ullem Scott B.","position":1,"cik":"0001446989","reported_name":"Ullem Scott B.","relationship":{"officer":true,"officer_title":"CVP, Chief Financial Officer"}}],"security":"Common Stock","published_at":"2026-05-09T01:16:34.000Z","date":"2026-05-07","kind":"tax_withholding","planned":false,"acquired":false,"shares":1373,"price":83.2,"value":114233.6,"ownership":{"direct":true},"balance_after":39575,"source":{"system":"sec-edgar","filing":"0001225208-26-005047","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005047/doc4.xml","form_type":"4"}},{"id":787479,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":48861,"kind":"person","name":"Davis Leslie C.","position":1,"cik":"0002021765","reported_name":"Davis Leslie C.","relationship":{"director":true}}],"security":"Common Stock","published_at":"2026-05-09T01:16:33.000Z","date":"2026-05-08","kind":"grant","planned":false,"acquired":true,"shares":3251,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units were granted on May 8, 2026 under the Edwards Lifesciences Corporation 2020 Nonemployee Directors Stock Incentive Program. They are scheduled to become 100% vested after the earlier of one year from the grant date or the Issuer's next annual meeting of stockholders."}],"balance_after":9834,"source":{"system":"sec-edgar","filing":"0001225208-26-005046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005046/doc4.xml","form_type":"4"}},{"id":787478,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Performance Rights","published_at":"2026-05-09T01:16:31.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":7850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Reflects the target number of shares (the Target Award) covered by restricted stock units granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to vest on May 7, 2029. The number of restricted stock units that vest will depend upon achievement of certain performance goals over a three-year performance period and will range from 0% to 200% of the Target Awards."}],"balance_after":7850,"derivative":{"exercise_date":"2029-05-07","underlying":"Common Stock","underlying_shares":7850},"source":{"system":"sec-edgar","filing":"0001225208-26-005045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005045/doc4.xml","form_type":"4"}},{"id":787477,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Employee Stock Option (Right to Acquire)","published_at":"2026-05-09T01:16:31.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":39900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments."}],"balance_after":39900,"derivative":{"exercise_price":82.76,"exercise_date":"2027-05-07","expiration_date":"2033-05-06","underlying":"Common Stock","underlying_shares":39900},"source":{"system":"sec-edgar","filing":"0001225208-26-005045","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005045/doc4.xml","form_type":"4"}},{"id":787476,"issuer":{"id":3026,"kind":"organization","name":"Edwards Lifesciences Corp","symbol":"EW"},"owners":[{"id":24768,"kind":"person","name":"Lippis Daniel J.","position":1,"cik":"0002004380","reported_name":"Lippis Daniel J.","relationship":{"officer":true,"officer_title":"CVP, TAVR"}}],"security":"Common Stock","published_at":"2026-05-09T01:16:31.000Z","date":"2026-05-08","kind":"tax_withholding","planned":false,"acquired":false,"shares":450,"price":82.76,"value":37242.0,"ownership":{"direct":true},"balance_after":40772.9103,"source":{"system":"sec-edgar","filing":"0001225208-26-005045","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1099800/000122520826005045/doc4.xml","form_type":"4"}}],"next_cursor":"2026-05-09T01:16:31.000000Z,787476"}